UnratedFood recall · FDA · Published December 13, 2018
SFI USA recalls Klaire Labs L-Glutathione capsules due to mislabeling
SFI USA recalls Klaire Labs Reduced L-Glut: 150mg capsules (SKU V799-10) that contain Lithium Orotate instead of L-Glutathione. This mislabeling could cause confusion about the product's actual contents.
“SFI USA recalls Klaire Labs L-Glutathione capsules due to mislabeling.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/17982-sfi-usa-recalls-klaire-labs-l-glutathione-capsules-due-to. Based on FDA recall #F-1186-2019 (https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-1186-2019%22&limit=1).
The FDA announced on Dec. 13, 2018, that ProThera, Inc. dba SFI USA voluntarily recalled Klaire Labs Reduced L-Glutathione capsules due to mis-packaging containing Lithium Orotate instead of the labeled ingredient. The agency classified the recall as Class II.
The product is labeled as Reduced L-Glutathione but actually contains Lithium Orotate. The FDA reported no specific incidents or injuries associated with this mis-packaging error.
Context
GovInfoNow's records show ProThera, Inc. dba SFI USA has one other recall on record since Jan. 17, 2019, involving melatonin lozenges contaminated with L-Theanine. Other recent recalls of similar products include Zarlengo Gelato Recall: Soy Lecithin Missing from Contains Statement (March 26, 2026), United Salt Corp Recalls Plain Salt Labeled as Iodized (May 14, 2026), and Zarlengo Chocolate Gelato Recall: Soy Lecithin Missing from Contains Statement (March 26, 2026).
How to tell if you have this one
Check for the SKU V799-10 and UPC code 709616799109 on the product packaging. The product was manufactured in 2018 with an expiration date of May 2020.
Look for the SKU V799-10 and UPC code 709616799109 on the product packaging.
Where it went and when
Where it was distributed
Distributed in 14 states, and outside the U.S.
Listed by the agency
Not listed
FDA distribution: “US distribution to the following: AL, AZ, CA, KS, LA, MI, MO, NH, NJ, NY, OR, PA, TX, and WA Foreign distribution to the following: Netherlands, Great Britain, and Korea” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, Arizona, California, Kansas, Louisiana, Michigan, Missouri, New Hampshire, New Jersey, New York, Oregon, Pennsylvania, Texas, Washington.
Recall timeline
FDA terminated this recall 4 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3FDA terminated the recall
4Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #F-1186-2019 (December 13, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for F-1186-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.